APACHE II Score Calculator

What Is the APACHE II Score? A Complete Guide

The APACHE II (Acute Physiology and Chronic Health Evaluation II) scoring system is one of the most widely used and extensively validated severity-of-disease classification systems in intensive care medicine. Developed in 1985 by William Knaus and colleagues at the George Washington University Medical Center, APACHE II provides a standardized method for quantifying the severity of illness in critically ill patients admitted to intensive care units (ICUs) worldwide. Since its introduction, the scoring system has become an indispensable tool for clinicians, researchers, and hospital administrators seeking to objectively assess patient acuity, predict outcomes, and compare the quality of care across different institutions.

The APACHE II score ranges from 0 to 71, although scores above 40 are rarely observed in clinical practice. The system evaluates patients based on three fundamental components: an Acute Physiology Score (APS) derived from 12 routine physiological measurements, an age adjustment, and a chronic health evaluation. By combining these elements, the APACHE II provides a comprehensive snapshot of a patient's condition within the first 24 hours of ICU admission, using the most abnormal (worst) values recorded during that period.

Why Is APACHE II Used in Intensive Care Units?

Intensive care units care for the most critically ill patients in any hospital, and the ability to objectively quantify illness severity serves multiple essential purposes. The APACHE II score fulfills several critical roles in modern ICU practice.

Outcome prediction: The primary purpose of APACHE II is to estimate hospital mortality risk. By converting a complex clinical picture into a single numerical score, physicians can communicate the gravity of a patient's condition to families, colleagues, and care teams in a standardized way. This estimation helps set realistic expectations and guides discussions about goals of care, including difficult decisions about the intensity of treatment.

Quality benchmarking: Hospital administrators and quality improvement teams use APACHE II scores to compare observed mortality rates against predicted mortality rates. If an ICU's actual death rate significantly exceeds the rate predicted by APACHE II, it may signal areas where care processes need improvement. Conversely, mortality rates lower than predicted suggest effective care delivery. This benchmarking function has made APACHE II a cornerstone of ICU quality assessment programs worldwide.

Clinical research: In clinical trials involving critically ill patients, APACHE II scores provide a standardized way to describe the baseline severity of illness in study populations. This allows researchers to ensure that treatment and control groups are comparable and helps readers of published studies understand the acuity level of the patients being studied. Many landmark ICU trials report APACHE II scores as a key baseline characteristic.

Resource allocation: By stratifying patients according to illness severity, APACHE II can help ICUs triage patients more effectively and allocate resources such as nursing staff, monitoring equipment, and specialized interventions where they are most needed.

The 12 Physiological Parameters Explained

The Acute Physiology Score (APS) component of APACHE II accounts for the largest portion of the total score and is derived from 12 commonly measured physiological variables. Each variable is assigned between 0 and 4 points based on how far the measured value deviates from the normal range, with higher deviations receiving more points. Here is a detailed explanation of each parameter:

1. Core Body Temperature

Temperature reflects the body's thermoregulatory status and is a key indicator of infection, inflammation, or hypothermia. Both extremes of temperature are dangerous: hyperthermia above 41 degrees Celsius suggests severe infection, heatstroke, or malignant hyperthermia, while hypothermia below 30 degrees Celsius indicates severe metabolic derangement or environmental exposure. Rectal temperature is the preferred measurement method for accuracy. Normal range (36.0 to 38.4 degrees Celsius) receives zero points.

2. Mean Arterial Pressure (MAP)

The MAP represents the average pressure in the arteries during one cardiac cycle and is a more accurate indicator of organ perfusion than systolic or diastolic pressure alone. It is calculated as (systolic pressure + 2 times diastolic pressure) divided by 3. A MAP between 70 and 109 mmHg is considered normal. Severely elevated MAP (above 160 mmHg) suggests a hypertensive emergency, while a MAP below 50 mmHg indicates profound hemodynamic compromise and shock.

3. Heart Rate

Heart rate reflects cardiovascular function and is influenced by numerous factors including cardiac output requirements, pain, anxiety, medications, and underlying cardiac pathology. The normal range of 70 to 109 beats per minute receives zero points. Extreme tachycardia (above 180 bpm) or bradycardia (below 40 bpm) each receive the maximum 4 points, reflecting the serious hemodynamic consequences of these extremes.

4. Respiratory Rate

Respiratory rate is a vital sign that reflects pulmonary function, metabolic demand, and acid-base status. A rate of 12 to 24 breaths per minute is normal. Tachypnea above 35 breaths per minute often indicates respiratory distress, metabolic acidosis, or sepsis, while bradypnea below 6 breaths per minute may signal impending respiratory failure or central nervous system depression.

5. Oxygenation

The oxygenation assessment uses two different methods depending on the fraction of inspired oxygen (FiO2) the patient is receiving. For patients on FiO2 of 0.5 or greater, the alveolar-arterial (A-a) oxygen gradient is used, which measures the efficiency of gas exchange across the lung membrane. For patients on lower oxygen concentrations (FiO2 less than 0.5), the partial pressure of arterial oxygen (PaO2) is used directly. This dual approach ensures accurate assessment regardless of the level of supplemental oxygen being administered.

6. Arterial pH

Arterial pH is a direct measure of acid-base balance and reflects the body's ability to maintain homeostasis. The normal range of 7.33 to 7.49 receives zero points. Severe alkalosis (pH above 7.70) and severe acidosis (pH below 7.15) both carry the maximum 4-point penalty. Arterial pH abnormalities are often the final common pathway of multiple organ dysfunction and metabolic derangement.

7. Serum Sodium

Sodium is the primary extracellular cation and plays a critical role in maintaining fluid balance, nerve conduction, and cellular function. Normal levels (130 to 149 mmol/L) receive zero points. Extreme hypernatremia (above 180 mmol/L) or hyponatremia (below 111 mmol/L) are life-threatening conditions that receive maximum points.

8. Serum Potassium

Potassium is essential for cardiac conduction and muscle function. The normal range of 3.5 to 5.4 mmol/L receives zero points. Both hyperkalemia (above 7.0 mmol/L) and hypokalemia (below 2.5 mmol/L) can cause fatal cardiac arrhythmias and receive maximum points in the APACHE II scoring system.

9. Serum Creatinine

Creatinine is a marker of kidney function. Normal levels (0.6 to 1.4 mg/dL) receive zero points. Elevated creatinine indicates renal impairment, and the APACHE II system doubles the creatinine points when acute renal failure (ARF) is present, reflecting the significantly worse prognosis associated with acute kidney injury in the ICU setting.

10. Hematocrit

Hematocrit measures the proportion of blood volume occupied by red blood cells. Normal values (30 to 45.9 percent) receive zero points. Elevated hematocrit may indicate dehydration or polycythemia, while severely low hematocrit (below 20 percent) suggests significant anemia or hemorrhage.

11. White Blood Cell Count

The white blood cell count reflects immune system activity and inflammation. Normal values (3.0 to 14.9 times 10 to the third per microliter) receive zero points. Extreme leukocytosis (above 40) often indicates overwhelming infection or leukemia, while leukopenia (below 1.0) may suggest bone marrow failure or severe sepsis with immune exhaustion.

12. Glasgow Coma Scale (GCS)

The GCS assesses the level of consciousness based on eye opening, verbal response, and motor response, with scores ranging from 3 (deep coma) to 15 (fully alert). The APACHE II system calculates GCS points as 15 minus the GCS value, meaning a fully conscious patient (GCS 15) contributes zero points, while a deeply comatose patient (GCS 3) contributes the maximum 12 points. This is the only parameter in APACHE II that can contribute more than 4 points to the total score.

Age and Chronic Health Scoring

Age Points

APACHE II recognizes that age is an independent predictor of ICU mortality. Older patients have diminished physiological reserves and reduced ability to recover from critical illness. The age scoring is straightforward: patients aged 44 years or younger receive zero points, those aged 45 to 54 receive 2 points, 55 to 64 receive 3 points, 65 to 74 receive 5 points, and patients aged 75 or older receive the maximum 6 points. This age adjustment ensures that the score accounts for the well-documented relationship between advancing age and increased mortality in the ICU.

Chronic Health Points

The chronic health evaluation component accounts for the patient's pre-existing health status, specifically the presence of severe organ system insufficiency or immunocompromised states. This includes conditions such as liver cirrhosis (biopsy-proven), New York Heart Association Class IV heart failure, severe chronic obstructive pulmonary disease, chronic dialysis, and immunosuppression. Patients with these conditions who are admitted as non-operative or emergency postoperative cases receive 5 points, while those admitted as elective postoperative patients receive 2 points. Patients without significant chronic health conditions receive zero points. This distinction reflects the substantially worse outcomes observed in chronically ill patients undergoing emergency surgery or medical admission compared to elective surgical procedures.

How to Calculate the APACHE II Score: Step by Step

1. Collect the worst values: During the first 24 hours of ICU admission, record the most abnormal (worst) value for each of the 12 physiological parameters. If a variable is not measured, assume it is normal (zero points).
2. Score each physiological variable: Using the established scoring tables, assign 0 to 4 points for each of the 12 variables based on how far the measured value deviates from normal. Note that GCS contributes 0 to 12 points (15 minus GCS value), and creatinine points are doubled in the presence of acute renal failure.
3. Sum the Acute Physiology Score: Add all 12 individual parameter scores to obtain the APS. The maximum possible APS is 60 points (although this is theoretically possible, such extreme scores are essentially never seen clinically).
4. Add age points: Based on the patient's age, add 0, 2, 3, 5, or 6 points.
5. Add chronic health points: Based on the patient's chronic health status and type of admission, add 0, 2, or 5 points.
6. Calculate the total: Sum the APS, age points, and chronic health points to obtain the final APACHE II score (range: 0 to 71).

Interpreting the Score and Mortality Prediction

The APACHE II score provides an estimated hospital mortality risk based on large-scale validation studies. The relationship between the score and mortality is approximately exponential: small increases in score at higher levels correspond to large increases in predicted mortality. The following general guidelines apply to non-operative medical admissions:

• Score 0-9 (Low Risk): Estimated mortality of 4-8%. These patients have relatively mild physiological derangements and generally good prognoses. Most will survive to hospital discharge with appropriate ICU care.
• Score 10-19 (Moderate Risk): Estimated mortality of 15-25%. These patients have significant physiological abnormalities requiring active monitoring and intervention. The majority will survive, but careful attention to evolving organ dysfunction is essential.
• Score 20-29 (High Risk): Estimated mortality of 40-55%. These patients are severely ill with multiple organ systems affected. Aggressive treatment is required, and goals of care discussions may be appropriate.
• Score 30-34 (Very High Risk): Estimated mortality of approximately 75%. These patients are critically ill with a high likelihood of death. Intensive support and honest discussions about prognosis are warranted.
• Score above 34 (Critical): Estimated mortality of approximately 85% or higher. Very few patients with scores in this range survive, and palliative care consultation should be considered alongside aggressive treatment.

It is important to emphasize that these mortality estimates are population-based approximations. Individual patient outcomes depend on numerous factors not captured by the score, including the specific diagnosis, response to treatment, timing of interventions, and quality of ICU care. The APACHE II score should never be used in isolation to make decisions about withdrawing or withholding treatment.

Limitations and Considerations

While APACHE II remains one of the most widely used ICU scoring systems, it has several important limitations that clinicians should be aware of:

• Dated calibration: The original APACHE II mortality predictions were calibrated using data from the early 1980s. Advances in critical care medicine since then mean that actual mortality rates are generally lower than APACHE II predictions for any given score. The system tends to overestimate mortality by current standards.
• Diagnosis-independent baseline: The basic APACHE II score does not incorporate the specific admitting diagnosis, although diagnostic category-specific coefficients were developed as supplementary adjustments. Two patients with the same APACHE II score but different underlying conditions (for example, diabetic ketoacidosis versus metastatic cancer) may have very different actual prognoses.
• Single time point: APACHE II captures only the first 24 hours of ICU admission. It does not account for the trajectory of illness, response to treatment, or complications that develop after the initial scoring period. A patient who improves rapidly after resuscitation may have the same APACHE II score as one who continues to deteriorate.
• Missing variables: When laboratory values are not measured (which is assumed to represent normal values), the score may underestimate severity in patients who were too unstable for certain tests to be performed.
• Lead-time bias: Patients transferred from other hospitals or step-down units may have had more extensive resuscitation before ICU admission, potentially resulting in lower APACHE II scores that underestimate their true severity of illness.
• Population specificity: APACHE II was developed and validated primarily in North American ICU populations. Its accuracy may vary in different geographic regions, healthcare systems, and patient populations.

APACHE II vs Other ICU Scoring Systems

Several alternative ICU scoring systems have been developed to address limitations of APACHE II or to serve different clinical purposes. Understanding how these systems compare helps clinicians choose the most appropriate tool for their needs.

Feature	APACHE II	SOFA	SAPS II
Year Developed	1985	1996	1993
Variables	12 physiologic + age + chronic health	6 organ systems	17 variables
Score Range	0-71	0-24	0-163
Timing	First 24 hours	Daily (serial)	First 24 hours
Primary Purpose	Mortality prediction	Organ dysfunction tracking	Mortality prediction
Serial Assessment	No (admission only)	Yes (daily)	No (admission only)
Ease of Use	Moderate	Simple	Moderate

SOFA (Sequential Organ Failure Assessment): Unlike APACHE II, the SOFA score is designed for serial (daily) assessment and focuses specifically on tracking organ dysfunction over time. It evaluates six organ systems (respiratory, coagulation, liver, cardiovascular, central nervous system, and renal) and is particularly useful for monitoring the progression or resolution of organ failure during the ICU stay. SOFA has become especially prominent since the 2016 Sepsis-3 definitions, which use SOFA score changes to define sepsis and septic shock.

SAPS II (Simplified Acute Physiology Score II): Developed in 1993 using data from European and North American ICUs, SAPS II uses 17 variables and provides mortality probability calculations. It was designed to be simpler to calculate than APACHE II while maintaining comparable predictive accuracy. Like APACHE II, it is an admission score based on the first 24 hours of ICU care.

APACHE III and APACHE IV: These are updated versions of the original APACHE system with more variables, better calibration, and improved statistical models. However, they are proprietary systems requiring commercial licenses, which has limited their widespread adoption compared to the freely available APACHE II.

Clinical Applications

The APACHE II scoring system serves numerous clinical and administrative purposes in modern healthcare:

• Triage and admission decisions: APACHE II scores can help determine which patients are likely to benefit most from ICU admission and which may be more appropriately managed in step-down units or general wards.
• Goals of care discussions: When combined with clinical judgment and patient values, APACHE II scores provide objective data that can inform discussions about treatment intensity, advance directives, and end-of-life planning.
• Clinical trial enrollment: Many critical care research studies use APACHE II scores to define inclusion criteria, stratify randomization, and describe study populations, enabling meaningful comparison of results across different trials and institutions.
• Performance benchmarking: By comparing observed-to-predicted mortality ratios (standardized mortality ratios, or SMRs), hospitals and ICUs can assess their performance relative to expected outcomes. An SMR below 1.0 indicates better-than-predicted outcomes.
• Insurance and reimbursement: Some healthcare payment systems use severity-of-illness scores like APACHE II to adjust reimbursement rates, recognizing that sicker patients require more resources and more expensive care.
• Staffing models: ICU staffing ratios and resource allocation can be informed by the aggregate acuity level of patients, as measured by tools like APACHE II, helping ensure adequate nurse-to-patient ratios during periods of high acuity.

Frequently Asked Questions